Generics Industry News Search
 |
|
|
|
|
|
|
April 2015 News Archive |
|
|
| |
|
The Medicines Company (MDCO) today announced that it has settled its litigation with Sun relating to MDCO's U.S. Patent No. 7,582,727 and U.S. Patent No. 7,598,343 covering Angiomax...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that its US subsidiary, Lupin yesterday has launched its Amlodipine and Valsartan tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
It's not just that Teva doesn't want the FDA to approve generics of its MS star, Copaxone. It really, really, really does not want the FDA to approve them, and it's filed yet another citizen's petition to the agency with a crop of reasons why it shouldn't...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an ANDA with the FDA seeking approval to market Ambrisentan tablets, 5 mg and 10 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo is pleased to announce that the company has receive final approvals from the FDA to manufacture and market Sildenafil injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A US appeals court said Tuesday that the $76 million in damages awarded to AstraZeneca in a patent infringement case involving its heartburn drug Prilosec must be cut back because of an improper calculation by the district court judge in the case...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the US launch of Norethindrone and Ethinyl Estradiol tablets (chewable) 0.8 mg/0.025 mg and Ferrous fumarate tablets, 75 mg (chewable)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark has been granted final ANDA approval from the FDA for Norethindrone acetate and Ethinyl Estradiol tablets USP, 0.5 mg / 2.5 mcg and 1mg / 5 mcg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Canadian Generic Pharmaceutical Association (CGPA) announced today the establishment of a new CGPA Biosimilars Board and the election of Michel Robidoux, President and General Manager of Sandoz Canada, as its inaugural Chair...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has received final approval from the FDA of its ANDA for Hydromorphone HCI extended-release tablets 8 mg, 12 mg and 16 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Natco, the generic drug maker best known for challenging pharmaceutical patents in India, is setting its sights on the US with products including a copy of Teva's blockbuster Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Biocon announced today that its Insulin glargine has been approved by COFEPRIS, the Mexican health authority, through its partner PiSA Farmaceutica...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo has received final approval from the FDA to manufacture and market Atracurium besylate injection, 10 mg/mL, 5 mL vials and 10 mg/mL, 10mL multi-dose vials...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics has been granted final approval by the FDA for the oral contraceptive for Levonorgestrel/Ethinyl Estradiol tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Turin Court has rejected AstraZeneca's claim appeal in the request for preliminary injunctions against Accord for Quetiapine SR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vanda today announced a February 29, 2016 trial date for two pending cases against Roxane regarding Roxane's submission of an ANDA to obtain approval to make and sell generic Fanapt (Iloperidone oral tablets)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its has entered into a settlement and license agreement with Pfizer to settle patent litigation relating to Mylan's ANDA filed with the FDA for Sildenafil citrate tablets 25 mg, 50 mg, and 100 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Depomed today announced it has entered into a settlement agreement with Actavis, Inc. in Depomed's patent infringement litigation related to Actavis's ANDA seeking approval to market generic versions of Depomed's Gralise (Gabapentin) 300 mg and 600 mg tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis urged a US appeals court on Monday to allow it to discontinue a top-selling Alzheimer's drug in favour of a pricier extended-release version, a move that New York's attorney general has said would suppress generic competition...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Strides Arcolab announced receipt of approval from US health regulator for selling medicine used for cleansing the bowel prior to colonoscopy...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vivus today announced that it has filed a lawsuit in the US District Court for the District of New Jersey against Teva...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo has received final approval from the FDA to manufacture and market Cefixime for oral suspension USP 100 mg/5 mL and 200 mg/5 mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has received final FDA approval for Triamcinolone acetonide topical aerosol, the generic version of Sun Pharma's Kenalog nasal spray...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Momenta today announced that the FDA has granted marketing approval of Sandoz's ANDA for once daily Glatopa 20 mg/mL, a generic equivalent of daily Copaxone 20 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Antares today announced that is has settled all litigation between Antares and Medac...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amerigen today announced that the FDA has granted tentative approval to the company's ANDA for a generic version of Bystolic...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Claris confirms that it has reached a settlement and license agreement; end all pending litigation with Fresenius Kabi with reference to the alleged infringement of a patent relating to Propofol injection 10 mg/mL, which is a generic version of Diprivan...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva has agreed to pay $512 million to settle a class action claiming that Cephalon, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Elite today announced the launch of generic Hydroxyzine HCI 10 mg, 25 mg and 50 mg tablets through Epic, a private pharmaceutical company located in Laurelton, NY...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Claris announced today that is has received the ANDA approval for Fluconazole injection in the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
On April 16, Perrigo announced it had received FDA approval and had launched the generic version of Sun Pharma's Kenalog nasal spray...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aceto today announced that Rising its finished dosage form generics subsidiary, is launching the 0.25 % and 0.5 % strengths of Timolol maleate ophthalmic solution and 0.3 % strength of Ofloxacin ophthalmic solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that is has launched generic Sofosbuvir 400 mg tablets under the brand name MyHep in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cipher today announced that the Court has issued an opinion in the claim construction hearing for the patent infringement suit by Ranbaxy, Sun, Galephar and Cipher against Watson related to Watson's ANDA for a generic version of Absorica...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
TWi today announced that it has entered into a settlement agreement with Takeda to settle and dismiss all outstanding patent litigation related to TW's generic Dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cipla today suggested to the Delhi High Court that it was ready to pay a "reasonable" royalty to Novartis if it is allowed to manufacture respiratory disease drug, Indaflo, which could serve 66,000 patients in India at a cheaper rate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI Laboratories a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its second ANDA to FDA of 2015...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announces the launch of Argatroban injection in 0.9% sodium chloride, 250 mg/250 mL for intravenous infusion only, in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced the launch of the generic equivalent to Abilify (Aripiprazole) tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun has bagged FDA approval for a painkiller tablet called Oxymorphone hydrochloride...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge announces the final approval by the FDA of the ANDA for Repaglinide tablets USP, which is being manufactured and supplied by Standard Chem. & Pharm in Taiwan...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
